HomeClinical TopicsFDA approves extended depth-of-focus IOL

FDA approves extended depth-of-focus IOL

On July 15, the Food and Drug Administration (FDA) approved Tecnis Symfony intraocular lens (IOL), the first IOL that provides cataract patients with an extended depth-of-focus, which helps improve their visual acuity at near, intermediate, and far distances. Read more


Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

NP taking pregnant woman's blood pressure

AHA: It’s Safe to Treat High Blood Pressure During Pregnancy

High blood pressure during pregnancy can present significant risks to mother and child, but practitioners have sometimes be hesitant to prescribe blood pressure medication...